✦ LIBER ✦

91 Sustained Therapeutic Benefit of Vedolizumab Throughout 1 Year in Crohn's Disease in Gemini II, a Randomized, Placebo-Controlled, Double-Blind, Multicenter Study

✍ Scribed by Rutgeerts, Paul J.; Sandborn, William; Reinisch, Walter; Xu, Jing; Milch, Catherine; Fox, Irving; Smyth, Michael D.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P323 Sustained therapeutic benefit of ve

✍ Sandborn, W.; Sands, B.; Rutgeerts, P.; Sankoh, S.; Rosario, M.; Milch, C.; Fox, 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 232 KB

Tu1138 Efficacy of Vedolizumab in Crohn'

✍ Hanauer, Stephen B.; Feagan, Brian G.; Macintosh, Donald G.; Xu, Jing; Milch, Ca 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 474 KB

Results from a phase II multicenter, dou

✍ Paul Michael Grossman; Farrell Mendelsohn; Timothy D. Henry; James B. Hermiller; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 159 KB

P300 Health related quality of life resu

✍ B. Feagan; C. Gasink; L.-L. Gao; M. Blank; J. Johanns; C. Guzzo; C.-F. Chiou; W. 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 67 KB

A Phase II, Randomized, Double-Blind, Mu

✍ Runlin Gao; Jian Zhang; Liuquan Cheng; Xuesi Wu; Wei Dong; Xinchun Yang; Tiancha 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 798 KB

A Multicenter, Randomized, Double-Blind,

✍ William J. Sandborn; Christopher Gasink; Long-Long Gao; Marion Blank; Jewel Joha 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 145 KB